Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kitty St Pierre

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Advances in Kidney Disease and Health|June 22, 2026
Autosomal Dominant Polycystic Kidney Disease: Genetic Insights, Phenotypic Spectrum, and Advances in Prognosis and TreatmentRu Sin Lim, Becky Mingyao Ma, Kitty St Pierre, et al.
Kidney International Reports|November 24, 2025
End Point Selection in ADPKD Clinical TrialsKitty St Pierre, Ragada El-Damanawi, Julia Jefferis, et al.
Journal of Clinical Epidemiology|May 7, 2025
Methods for living guidelines: paper 6: insights from Australian Living Evidence Collaboration's (ALEC) use of existing systematic reviews in living guideline developmentKitty St Pierre, Brydee Cashmore, Miranda S Cumpston, et al.
The Cochrane Database of Systematic Reviews|October 2, 2024
Interventions for preventing the progression of autosomal dominant polycystic kidney diseaseKitty St Pierre, Brydee A Cashmore, Davide Bolignano, et al.
Internal Medicine Journal|April 21, 2026
Caring for Australians and New ZealandeRs with kidney Impairment guideline commentary on kidney disease: improving global outcomes 2025 guidelines for diagnosis and management of autosomal polycystic kidney diseaseMia E Abdy, Kitty St Pierre, Emily Major, et al.
Trials|August 26, 2025
Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney diseaseKitty St Pierre, Ragada El-Damanawi, David W Johnson, et al.
Expert Review of Clinical Pharmacology|December 24, 2025
Shaping future deprescribing priorities: outcomes of a World Café stakeholder workshopWilliam Manning Olsen, Kitty St Pierre, Wade Thompson, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Advances in Kidney Disease and Health|June 22, 2026
Autosomal Dominant Polycystic Kidney Disease: Genetic Insights, Phenotypic Spectrum, and Advances in Prognosis and TreatmentRu Sin Lim, Becky Mingyao Ma, Kitty St Pierre, et al.
Kidney International Reports|November 24, 2025
End Point Selection in ADPKD Clinical TrialsKitty St Pierre, Ragada El-Damanawi, Julia Jefferis, et al.
Journal of Clinical Epidemiology|May 7, 2025
Methods for living guidelines: paper 6: insights from Australian Living Evidence Collaboration's (ALEC) use of existing systematic reviews in living guideline developmentKitty St Pierre, Brydee Cashmore, Miranda S Cumpston, et al.
The Cochrane Database of Systematic Reviews|October 2, 2024
Interventions for preventing the progression of autosomal dominant polycystic kidney diseaseKitty St Pierre, Brydee A Cashmore, Davide Bolignano, et al.
Internal Medicine Journal|April 21, 2026
Caring for Australians and New ZealandeRs with kidney Impairment guideline commentary on kidney disease: improving global outcomes 2025 guidelines for diagnosis and management of autosomal polycystic kidney diseaseMia E Abdy, Kitty St Pierre, Emily Major, et al.
Trials|August 26, 2025
Implementation of Metformin Therapy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): study protocol for a phase III, multi-centre, randomized, placebo-controlled trial evaluating the long-term efficacy of metformin in slowing the rate of kidney function decline in patients with autosomal dominant polycystic kidney diseaseKitty St Pierre, Ragada El-Damanawi, David W Johnson, et al.
Expert Review of Clinical Pharmacology|December 24, 2025
Shaping future deprescribing priorities: outcomes of a World Café stakeholder workshopWilliam Manning Olsen, Kitty St Pierre, Wade Thompson, et al.
Pageof 1